Online Spaced Education to Improve Fall Prevention by Patients With Multiple Sclerosis

February 28, 2019 updated by: Hospital Israelita Albert Einstein

Impact of Online Spaced Education on Long-term Retention of Knowledge About Fall Prevention by Patients With Multiple Sclerosis

Multiple sclerosis (MS) is a chronic, progressive and neurodegenerative inflammatory disease that affects young adults. In many countries it has been described as the main cause of neurological incapacity in this age group. Due to the neurological impairment, patients with multiple sclerosis have a high incidence of fall. According to studies, MS patients fall three times more than general population. In the present study, the question to be answered is: education of individuals with MS on fall prevention using the method of online spaced education provides better retention of knowledge than the traditional method? This is a clinical trial to compare two methods of education of MS patients for prevention of fall. First stage: Development and validation of materials. Step two: Pilot questions with MS patients. Step three: Intervention and evaluation of outcome.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sao Paulo
      • São Paulo, Sao Paulo, Brazil, 05652000
        • Recruiting
        • Sociedade Benef Israelitabras Hospital Albert Einstein
        • Contact:
        • Principal Investigator:
          • Oscar P Santos, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Multiple sclerosis diagnosis
  • Accept to be part in the study
  • Have valid e-mail address

Exclusion Criteria:

- Healthcare professionals;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Online Spaced Education
The intervention cohort will participate in an online spaced education on fall prevention education developed for patients with multiple sclerosis.
Investigators created a set of fall prevention strategies for multiple sclerosis patients into an evidence-based form of online education, termed 'spaced education' (SE). Based upon two psychology research findings (the spacing and testing effects), spaced education has been shown in randomized trials to improve knowledge acquisition, boosts learning retention for up to two years, and durably improves changes in behavior.
Active Comparator: Brochure Education
The control cohort will receive the fall prevention education in bolus through a Brochure developed by the National Multiple Sclerosis Society. The brochure was translated to portuguese and will be used in the study with authorization of the Society.
The investigators translated and validated the Minimizing Your Risk of Falls A GUIDE FOR PEOPLE WITH MS brochure developed by the National Multiple Sclerosis Society. The control cohort will receive the main education model for patients that has been used in the past few years.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in test scores between cohorts measured in weeks 1-24
Time Frame: Months 1-6
Test scores on fall prevention strategies tests in both cohorts will be registered and compared in weeks 1, 12 and 24
Months 1-6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fall rate
Time Frame: Months 1-6
Number of self-reported falls registered by the patients in both cohorts will be compared in weeks 1, 12 and 24
Months 1-6
Adherence to fall prevention strategies
Time Frame: Months 1-6
The study will apply the Falls Prevention Strategies Survey in both cohorts in weeks 1, 12 and 24. It is a self-report instrument addressing protective behaviors related to fall risk among adults with multiple sclerosis (MS) (eg, monitoring MS symptoms, wearing proper footwear, modifying activities). Response options reflect the frequency with which the respondent engages in the behavior (ie, never, sometimes, regularly)
Months 1-6
Individuals satisfaction with the fall prevention education method
Time Frame: Months 3-6
Individuals will be asked to evaluate their satisfaction with the method they were signed in the study by a five-point Likert scale (very dissatisfied, dissatisfied, neutral, satisfied, very satisfied). Answers will be compared between both cohorts in weeks 12 and 24.
Months 3-6
Baseline knowledge levels of patients assessed via their initial responses to the questions
Time Frame: Month 1
Previous knowledge about fall prevention strategies will be evaluated in week 1 in both cohorts and compared
Month 1
Pre and post-test performances differences by age
Time Frame: Month 1-6
Patient performance will be evaluated in both cohorts and compared by age in weeks 1, 12 and 24
Month 1-6
Pre and post-test performances differences by gender
Time Frame: Month 1-6
Patient performance will be evaluated in both cohorts and compared by gender in weeks 1, 12 and 24
Month 1-6
Pre and post-test performances differences by history of falls
Time Frame: Months 1-6
Patient performance in pre and post-tests will be evaluated in both cohorts and will be compared between fallers and non-fallers in the group and between the cohorts in weeks 1, 12 and 24. We will consider fallers the individuals, in both groups, that have at least one reported fall in the past six months in the enrollment in the study.
Months 1-6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Oscar F Santos, PhD, MD
  • Principal Investigator: Eliseth R Leão, PhD, Researcher

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 21, 2019

Primary Completion (Anticipated)

October 15, 2019

Study Completion (Anticipated)

November 15, 2019

Study Registration Dates

First Submitted

October 29, 2018

First Submitted That Met QC Criteria

November 7, 2018

First Posted (Actual)

November 9, 2018

Study Record Updates

Last Update Posted (Actual)

March 1, 2019

Last Update Submitted That Met QC Criteria

February 28, 2019

Last Verified

October 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

We do not plan to share IPD with other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Education of Patients

Clinical Trials on Online Spaced Education

3
Subscribe